DALLAS, TX--(Marketwire - July 06, 2010) - Erchonia, the global leader in low level laser healthcare applications, today launches its Zerona body-contouring laser in the Czech Republic. Erchonia CZ will exclusively market and sell the non-invasive Zerona device throughout the Czech Republic and Slovakia. Today's announcement is the latest in a series of international distribution efforts which include launching Zerona in the Middle East and Hong Kong.
"We are certain Erchonia's research and development combined with our local market knowledge will make Zerona as successful here as it is in the U.S.," says Rudolf Kubat, CEO of Erchonia CZ. "The Zerona has incredible potential for us."
"We welcome Mr. Kubat to the Erchonia worldwide distribution network and look forward to working together to bring our life-changing technology to people throughout Central Europe," adds Steve Shanks, president of Erchonia.
In contrast to high-power, high-heat lasers that are used in various surgical procedures, Erchonia's Zerona laser produces a low-level output that has no thermal effect on the body's tissue. Instead, the painless, non-invasive laser creates tiny pores in fat cells from which fat is released and carried away as waste by the lymphatic system.
For more information, please visit www.erchonia.com or www.erchonia.cz.
Erchonia is the global leader in low level laser therapy and healthcare applications. Over the last 15 years Erchonia has been conducting research & development with the world's leading physicians to advance the science of low level lasers. Prior to market introduction, all Erchonia lasers are proven to be safe and effective through independent clinical trials. Currently thousands of Erchonia's lasers are used daily to reduce body fat, eliminate pain, accelerate healing, and treat acne. For additional information, visit www.erchonia.com.
About Erchonia CZ
Erchonia CZ is an independent entrepreneurial trading company, which has exclusive licensing distribution rights for Erchonia products for the Czech and Slovak Republics. Its mission is to enable European patients' access to therapies based on 3LT Low Level Laser Therapy technologies. For additional information, visit www.erchonia.cz.